Globus Medical Stock Analysis (NYSE:GMED)
Globus Medical Analysis Video
View Globus Medical stock analysis video. This is our GMED analyst opinion covering the buy and sell arguments for GMED stock.
Globus Medical Inc Stock Rating (4/5)
Our Globus Medical stock opinion is based on fundamentals of the company. This Globus Medical stock analysis is based on latest Q1 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.
Should you buy GMED stock?
- Globus Medical's average operating margin of 26.1% was exceptional.
- LTM Net margins were good at 18.1% for Globus Medical.
- The company has an operating cash flow which is 1.9 times the net income.
- Globus Medical generates a high return on invested capital of 19.9%.
- Return On Equity (ROE) which is a measure of the company's profitability, looks great for Globus Medical at 13%.
- The company has a good Free Cash Flow (FCF) margin of 26.9%.